Article Name Predictive Diagnostics
GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety
19th February, 2024
Transforming the Lives of 1 Lakh Preterm Infants in India through Innovative Healthcare Solutions
30th January, 2024
Care is becoming more personalized. Innovation cycles are growing shorter and shorter. Healthcare companies are increasingly looking for ways to eliminate waste and complexity. These are only a few of the reasons why 3D printing has become such an invaluable tool for MedTech research and design teams. 3D printing can make the impractical a reality. It can help providers customize devices to meet the unique care needs of individual patients almost immediately. It’s now even possible to 3D print medicine and simulated body parts.
30th January, 2024
The National University of Singapore's Mechanobiology Institute (MBI) has recently secured a substantial S$49 million funding boost from the National Research Foundation (NRF) to propel advancements in mechanobiology. This funding, spread over seven years starting from December 2023, will be instrumental in conducting research to address age-related loss of biomechanical functions, particularly focusing on ailments such as infertility, chronic inflammatory diseases, muscle atrophy, and cancer.
29th January, 2024
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates
26th January, 2024
The world is finally paying attention to the impact of climate change on neglected diseases. What we need now is medical innovation.
08th January, 2024
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.
08th January, 2024
Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets by 2030.
08th January, 2024
Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.
05th January, 2024
Dr. Joshua Langston Assumes Role of Managing Partner and CEO at Urology of Virginia
02nd January, 2024
Groundbreaking Solution Identifies Undiagnosed AFib and Speeds Treatments Proven to Prevent Strokes
18th December, 2023
The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW's State-of-the-Art Technology for the Safe Management of Frozen Eggs and Embryos Providing a New Standard of Care for Fertility Patients
18th December, 2023
EONIS Q System enabling faster, simplified newborn screening for SMA and SCID
11th December, 2023
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
04th December, 2023
The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.
15th November, 2023
AI-driven care diagnostic imaging and care coordination to streamline physician workflows for timely and efficient patient care delivery
15th November, 2023
Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regions. Large players are very intent on tapping the large market potential in Asia. Many global companies have set up local presence in Asian countries and local production through original equipment manufacturer (OEM) partners in the countries to bring down the cost of their solutions, and more companies are expected to follow
06th November, 2023
Gamma Tech will distribute Pearl’s flagship AI solution, Second Opinion®, to the ANZ dental markets
02nd November, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer